Key points are not available for this paper at this time.
From 2009 to 2018, prevalence of DME or VTDR increased among Medicare Part B FFS beneficiaries alongside an increase in anti-VEGF treatment and a decline in laser photocoagulation and vitrectomy.
Lundeen et al. (Thu,) studied this question.